Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Related Articles by Review for PubMed (Select 19811285)

1.
2.

HMGB1: a signal of necrosis.

Raucci A, Palumbo R, Bianchi ME.

Autoimmunity. 2007 Jun;40(4):285-9. Review.

PMID:
17516211
3.

HMG1 and 2: architectural DNA-binding proteins.

Thomas JO.

Biochem Soc Trans. 2001 Aug;29(Pt 4):395-401. Review.

PMID:
11497996
4.

HMGB1, a novel inflammatory cytokine.

Yamada S, Maruyama I.

Clin Chim Acta. 2007 Jan;375(1-2):36-42. Epub 2006 Jul 25. Review.

PMID:
16979611
5.

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).

van Beijnum JR, Buurman WA, Griffioen AW.

Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Review.

PMID:
18264787
6.

HMGB1 in sepsis.

Andersson U, Tracey KJ.

Scand J Infect Dis. 2003;35(9):577-84. Review.

PMID:
14620138
7.

High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.

Voll RE, Urbonaviciute V, Herrmann M, Kalden JR.

Isr Med Assoc J. 2008 Jan;10(1):26-8. Review.

8.

Dealing with death: HMGB1 as a novel target for cancer therapy.

Lotze MT, DeMarco RA.

Curr Opin Investig Drugs. 2003 Dec;4(12):1405-9. Review.

PMID:
14763124
9.

High-mobility group box 1 (HMGB1) protein: friend and foe.

Ulloa L, Messmer D.

Cytokine Growth Factor Rev. 2006 Jun;17(3):189-201. Epub 2006 Mar 2. Review.

PMID:
16513409
10.

Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors.

Rauvala H, Rouhiainen A.

Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):164-70. doi: 10.1016/j.bbagrm.2009.11.012. Epub 2009 Nov 13. Review.

PMID:
19914413
11.

Masquerader: high mobility group box-1 and cancer.

Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT.

Clin Cancer Res. 2007 May 15;13(10):2836-48. Review.

12.

Is HMGB1 an osteocyte alarmin?

Bidwell JP, Yang J, Robling AG.

J Cell Biochem. 2008 Apr 15;103(6):1671-80. Review.

PMID:
17948903
13.

High mobility group box-1 and cardiovascular diseases.

Ding HS, Yang J.

Saudi Med J. 2010 May;31(5):486-9. Review.

PMID:
20464035
14.

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.

Pisetsky DS, Erlandsson-Harris H, Andersson U.

Arthritis Res Ther. 2008;10(3):209. doi: 10.1186/ar2440. Epub 2008 Jun 30. Review.

15.

High-mobility group protein box-1 and its relevance to cerebral ischemia.

Yang QW, Wang JZ, Li JC, Zhou Y, Zhong Q, Lu FL, Xiang J.

J Cereb Blood Flow Metab. 2010 Feb;30(2):243-54. doi: 10.1038/jcbfm.2009.202. Epub 2009 Sep 30. Review.

16.

High mobility group box protein-1 in HIV-1 infection.

Trøseid M, Sönnerborg A, Nowak P.

Curr HIV Res. 2011 Jan;9(1):6-10. Review.

PMID:
21198433
17.

Mechanisms of disease: a 'DAMP' view of inflammatory arthritis.

Foell D, Wittkowski H, Roth J.

Nat Clin Pract Rheumatol. 2007 Jul;3(7):382-90. Review.

PMID:
17599072
18.

High mobility group box 1 protein, a cue for stem cell recruitment.

Palumbo R, Bianchi ME.

Biochem Pharmacol. 2004 Sep 15;68(6):1165-70. Review.

PMID:
15313414
19.

RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease.

Rauvala H, Rouhiainen A.

Curr Mol Med. 2007 Dec;7(8):725-34. Review.

PMID:
18331230
20.

HMGB1 loves company.

Bianchi ME.

J Leukoc Biol. 2009 Sep;86(3):573-6. doi: 10.1189/jlb.1008585. Epub 2009 May 4. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk